Showing results (41-50 of 1,986) with videos related to
Sort By:
Pageof 199
The Pharmacogenomics Journal|August 22, 2003
Potential clozapine target sites on peripheral hematopoietic cells and stromal cells of the bone marrowA Pereira, A McLaren, W R Bell, et al.Brain Topography|January 1, 1993
Comparison of high resolution EEG methods having different theoretical basesP L Nunez, R B Silberstein, P J Cadusch, et al.Molecular Psychiatry|July 13, 2000
Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neuronsD Lee, W Huang, L Wang, et al.Neurochemistry International|April 23, 1999
No change in the density of the serotonin1A receptor, the serotonin4 receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophreniaB Dean, E Tomaskovic-Crook, K Opeskin, et al.Schizophrenia Research|June 27, 2000
Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophreniaD Pralong, E Tomaskovic-Crook, K Opeskin, et al.Neuroimage|October 22, 2003
Cortical neurophysiology of anticipatory anxiety: an investigation utilizing steady state probe topography (SSPT)M Gray, A H Kemp, R B Silberstein, et al.East African Medical Journal|June 1, 1994
Umbilical vein injection for retained placenta: clinical feasibility study of a new techniqueA Pipingas, A M Gulmezoglu, F F Mitri, et al.Evolution & Development|May 20, 2003
Variation of tooth number in mammalian dentition: connecting genetics, development, and evolutionSergio R P LineMolecular Medicine (Cambridge, Mass.)|December 16, 1998
No association between the serotonin transporter-linked promoter region polymorphism and either schizophrenia or density of the serotonin transporter in human hippocampusL Naylor, B Dean, A Pereira, et al.Molecular Psychiatry|March 1, 2003
Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorderE A Thomas, B Dean, E Scarr, et al.Pageof 199